CSIMarket
 


Celcuity Inc   (CELC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Celcuity Inc 's Tangible Leverage Ratio

CELC's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




CELC Tangible Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity Change -41.56 % 96.74 % 74.96 % 487.16 % 441.16 %
Y / Y Total Liabilities Change 25.36 % 21.67 % 1442.13 % 1270.76 % 1407.23 %
Tangible Leverage Ratio MRQ 0.5 0.36 0.3 0.25 0.23
Overall Ranking # 1132 # 0 # 0 # 0 # 740
Seq. Tangible Equity Change -18.17 % -13.57 % -10.44 % -7.74 % 175.48 %
Seq. Total Liabilities Change 14.56 % 3.31 % 6.95 % -0.96 % 11.19 %



Tangible Leverage Ratio third quarter 2022 Comment
Due to net new borrowings of 14.56%, Tangible Leverage Ratio detoriated to 0.5, above company's average Tangible Leverage Ratio.

Within Medical Laboratories industry in the third quarter 2022, 22 other companies have achieved lower Tangible Leverage Ratio than Celcuity Inc . While Tangible Leverage Ratio total ranking has deteriorated compare to the previous quarter from 0 to 1132.

Explain Tangible Leverage Ratio?
What is CELC Market Share?
Tangible Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Medical Laboratories Industry # 23
Healthcare Sector # 507
Overall Market # 1132


Tangible Leverage Ratio Statistics
High Average Low
0.58 0.14 0.01
(Jun 30 2021)   (Sep 30 2017)




Financial Statements
Celcuity Inc 's Tangible Equity $ 44 Millions Visit CELC's Balance sheet
Celcuity Inc 's Total Liabilities $ 22 Millions Visit CELC's Balance sheet
Source of CELC's Sales Visit CELC's Sales by Geography


Cumulative Celcuity Inc 's Tangible Leverage Ratio

CELC's Tangible Leverage Ratio for the trailling 12 Months

CELC Tangible Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity TTM Growth -41.56 % 96.74 % 74.96 % 487.16 % 441.16 %
Y / Y Total Liabilities TTM Growth 25.36 % 21.67 % 1442.13 % 1270.76 % 1407.23 %
Tangible Leverage Ratio TTM 0.34 0.28 0.3 0.25 0.24
Total Ranking TTM # 791 # 711 # 702 # 683 # 530
Seq. Tangible Equity TTM Growth -18.17 % -13.57 % -10.44 % -7.74 % 175.48 %
Seq. Total Liabilities TTM Growth 14.56 % 3.31 % 6.95 % -0.96 % 11.19 %


TTM Tangible Leverage Ratio Comment
On the trailing twelve months basis Due to net new borrowings of 14.56%, Tangible Leverage Ratio improved to 0.34, a new company high.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Laboratories industry 18 other companies have achieved lower Tangible Leverage Ratio than Celcuity Inc . While total ranking remained unchanged compare to previous quarter at no. 791.

Explain Tangible Leverage Ratio?
What is CELC Market Share?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 19
Healthcare Sector # 404
Within the Market # 791


TTM Tangible Leverage Ratio Statistics
High Average Low
0.34 0.15 0.04
(Sep 30 2022)   (Jun 30 2019)




Companies with similar Tangible Leverage Ratio in the quarter ending Sep 30 2022, within Medical Laboratories Industry Tangible Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Tangible Equity
American Shared Hospital Services  0.92 $ 22.194  Millions$ 24.084  Millions
Exagen Inc   0.88 $ 44.402  Millions$ 50.680  Millions
Malachite Innovations Inc   0.86 $ 1.600  Millions$ 1.856  Millions
Biocept Inc   0.86 $ 23.584  Millions$ 27.518  Millions
Aclarion Inc   0.68 $ 1.168  Millions$ 1.716  Millions
Vyant Bio Inc   0.66 $ 9.199  Millions$ 13.840  Millions
Psychemedics Corp  0.66 $ 7.771  Millions$ 11.722  Millions
Enzo Biochem Inc   0.66 $ 24.802  Millions$ 37.538  Millions
Yield10 Bioscience inc   0.56 $ 4.052  Millions$ 7.220  Millions
Celcuity Inc   0.50 $ 21.766  Millions$ 43.525  Millions
Arrowhead Pharmaceuticals Inc   0.39 $ 158.669  Millions$ 406.377  Millions
Veracyte Inc   0.36 $ 69.959  Millions$ 194.750  Millions
Incyte Corporation  0.33 $ 1,280.451  Millions$ 3,936.455  Millions
Personalis Inc   0.31 $ 75.462  Millions$ 242.399  Millions
Caredx Inc   0.30 $ 107.832  Millions$ 355.301  Millions
Butterfly Network Inc   0.29 $ 99.621  Millions$ 343.637  Millions
Dermtech Inc   0.25 $ 39.075  Millions$ 154.988  Millions
Ispecimen inc   0.25 $ 5.516  Millions$ 22.423  Millions
Bionexus Gene Lab Corp   0.21 $ 1.363  Millions$ 6.424  Millions
Science 37 Holdings Inc   0.17 $ 26.218  Millions$ 158.603  Millions
Castle Biosciences Inc   0.17 $ 46.378  Millions$ 281.076  Millions
Somalogic Inc   0.15 $ 85.574  Millions$ 575.505  Millions
Absci Corp  0.14 $ 31.743  Millions$ 219.142  Millions
Bioaffinity Technologies Inc   0.12 $ 1.464  Millions$ 12.599  Millions

Date modified: 2022-11-12T17:44:06+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VCOR's Profile

Stock Price

VCOR's Financials

Business Description

Fundamentals

Charts & Quotes

VCOR's News

Suppliers

VCOR's Competitors

Customers & Markets

Economic Indicators

VCOR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071